NASDAQ:PTXP PennTex Midstream Partners (PTXP) Stock Price, News & Analysis → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free PTXP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$20.00▼$20.0050-Day Range N/A52-Week Range$14.56▼$20.17VolumeN/AAverage Volume163,825 shsMarket CapitalizationN/AP/E Ratio14.49Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get PennTex Midstream Partners alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About PennTex Midstream Partners Stock (NASDAQ:PTXP)PennTex Midstream Partners, LP, focuses on owning, operating, acquiring and developing midstream energy infrastructure assets in North America. The Company owns and operates midstream gathering, processing and transportation assets in northern Louisiana. The Company provides natural gas gathering and processing and residue gas and natural gas liquid (NGL) transportation services to producers focused on the Cotton Valley formation in northern Louisiana. The Company's assets primarily consisted of natural gas gathering pipeline, two 200 million cubic feet per day (MMcf/d) design-capacity cryogenic natural gas processing plants, and residue gas and NGL transportation pipelines, as of December 31, 2016. In addition to providing midstream services to its primary customer with its existing assets, the Company pursues other opportunities for organic development and growth as producers in its region continue to develop their acreage.Read More Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> PTXP Stock News HeadlinesNovember 20, 2023 | morningstar.comHess Midstream LP Class A HESMJune 8, 2022 | investing.comPenntex Midstream Partners LP (PTXP)See More Headlines Receive PTXP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PennTex Midstream Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:PTXP CUSIPN/A CIK1617798 Webpenntex.com Phone+1-713-9897560FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio14.49 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMatthew S. Ramsey J.D.Chairman of the Board, President, Chief Operating OfficerKelcy L. WarrenChief Executive OfficerThomas E. LongChief Financial Officer, (Principal Financial Officer), DirectorA. Troy SturrockSenior Vice President, Controller and Principal Accounting OfficerStephen M. MooreVice President, General Counsel, SecretaryThomas P. MasonDirectorMarshall S. McCrea IIIDirectorRobert W. JordanIndependent DirectorDavid C. LawlerIndependent DirectorRichard S. WalkerIndependent DirectorMore Executives PTXP Stock Analysis - Frequently Asked Questions Is PennTex Midstream Partners a good dividend stock? PennTex Midstream Partners (NASDAQ:PTXP) pays an annual dividend of $1.18 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 85.51%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for PTXP. What other stocks do shareholders of PennTex Midstream Partners own? Based on aggregate information from My MarketBeat watchlists, some companies that other PennTex Midstream Partners investors own include Allena Pharmaceuticals (ALNA), Arbutus Biopharma (ABUS), Ampliphi Biosciences (APHB), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS), Aquinox Pharmaceuticals (AQXP). When did PennTex Midstream Partners IPO? PennTex Midstream Partners (PTXP) raised $226 million in an initial public offering on Thursday, June 4th 2015. The company issued 11,300,000 shares at a price of $19.00-$21.00 per share. Citigroup, Barclays, RBC Capital Markets and Wells Fargo Securities acted as the underwriters for the IPO and Deutsche Bank Securities, J.P. Morgan, SunTrust Robinson Humphrey, Tudor, Pickering, Holt & Co., Raymond James, Baird, Stifel and Wunderlich were co-managers. This page (NASDAQ:PTXP) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIYour Money is Not SafeAmerican AlternativeHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceSHOCKING Crypto Leak…Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PennTex Midstream Partners, LP Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.